The link between ERRα/POSTN in the clinical models was confirmed by our meta-analyses of bone metastases and in tumor adjacent tissues in primary tumors, which suggests that POSTN may constitute a new prognostic marker in association with ERRα. The gene discussed is POSTN; the disease is neoplasm.